- Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraJohn F Brothers
Bioinformatics Program, Boston University, Boston, MA, USA
BMC Med 11:168. 2013..This review highlights recent genetic, transcriptomic and epigenomic biomarkers that are emerging as tools for the early detection of lung cancer both in the diagnostic and screening setting. ..
- Transcriptomic studies of the airway field of injury associated with smoking-related lung diseaseAdam C Gower
Boston University School of Medicine, Boston, MA 02118, USA
Proc Am Thorac Soc 8:173-9. 2011....